5 lessons to master clinical data aggregation, transformation, cleaning and analytics to reduce cost, risk and time

Interest in the medical use of cannabis and cannabinoids continues to grow as patients and caregivers consider this option for treatment of unmet medical needs. Ever growing efforts to legalize cannabinoids in the US and Canada are creating an increased need to evaluate safe and effective use.

Presentation will cover four key strategic questions that each biopharmaceutical company should be able to answer prior to launching a new product, outline the types of analyses required to address those questions and provide examples of the insights that these tools have generated.